Published in Blood Weekly, February 2nd, 2012
"From January 2007 to December 2010, 176 patients (mean age, 48 +/- 16; range, 14-78 years) with ALF refractory to conventional therapy were supported with vv-ECMO. The general indication for vv-ECMO was a partial oxygen pressure/fraction of inspired oxygen (FIO2) < 80 mm Hg under a FIO2 of 1.0, a positive end-expiratory pressure of 18 cm H2O, and refractory respiratory...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.